NUCLEIC ACID SEQUENCES SCIENTIFIC

Brand Owner (click to sort) Address Description
LOCIPAINT Acuity Spatial Genomics, Inc. 112 Robin Hill Road Santa Barbara CA 93117 Nucleic acid sequences for scientific and research use; DNA and RNA strands for scientific and research use; Probes, being biochemical preparations, for scientific and research use; Reagents for scientific and research use; Kits comprised of probes, being biochemical preparations, nucleic acid sequences, DNA and RNA strands, and reagents, all of the foregoing for scientific and research use; Diagnostic assays for scientific and research use; Biological preparations for use in industry and science;
NEUROPAINT Acuity Spatial Genomics, Inc. 112 Robin Hill Road Santa Barbara CA 93117 Nucleic acid sequences for scientific and research use; DNA and RNA strands for scientific and research use; Probes, being biochemical preparations, for scientific and research use; Reagents for scientific and research use; Kits comprised of probes, being biochemical preparations, nucleic acid sequences, DNA and RNA strands, and reagents, all of the foregoing for scientific and research use; Diagnostic assays for scientific and research use; Biological preparations for use in industry and science;
ONCOPAINT Acuity Spatial Genomics, Inc. 112 Robin Hill Road Santa Barbara CA 93117 Nucleic acid sequences for scientific and research use; DNA and RNA strands for scientific and research use; Probes, being biochemical preparations, for scientific and research use; Reagents for scientific and research use; Kits comprised of probes, being biochemical preparations, nucleic acid sequences, DNA and RNA strands, and reagents, all of the foregoing for scientific and research use; Diagnostic assays for scientific and research use; Biological preparations for use in industry and science;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anaemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.